Multiple sclerosis: treatment of its symptoms
Jan. 31, 2021
Professor of Neurology
University of Chicago
Editorial Board Member since 2000: Neuroimmunology
Clinical Interests: Neuromyelitis optica, multiple sclerosis, tetanus, neuroimmunology
Dr. Reder of the University of Chicago received honorariums from Bayer, Biogen Idec, Caremark Rx, Genentech, Genzyme, Novartis, Mallinckrodt, Mylan, Serono, and Teva-Marion for service on advisory boards and as a consultant, and stock options from NKMax America for advisory work.